Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105,000 people of more than 140 nationalities work at Novartis around the world. For more information visit: www.novartis.com
GSK is a science-led global healthcare company on a mission to research, develop, manufacture and market innovative medicines and vaccines to unite science, technology and talent to get ahead of disease together. GSK has a 300-year global legacy, and for more than 65 years has been operating, employing and investing in the Gulf Cooperation Council region. We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients. We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries.
We are focused on creating genuinely innovative medicines and improving access to them. In this way, we deliver the greatest benefit to patients, healthcare systems and societies globally. We have three priorities designed to deliver our growth through innovation strategy. Accelerate Innovative Science: Accelerating the next wave of new molecular entities, building our capabilities in immunology and rare diseases, pursuing new scientific modalities and driving R&D productivity Deliver Growth and Therapy Area Leadership: Meeting our growth and profitability goals through successful innovation and commercial excellence, as well as completing the Alexion acquisition Be a Great Place to Work: Contributing to the enterprise and to society, with a focus on inclusion and diversity, lifelong learning, improving access to healthcare, environmental protection, and ethics and transparency, as well as delivering our Ambition Zero Carbon program. Inspired by our Values and what science can do, we are focused on accelerating the delivery of life-changing medicines that create enduring value for patients and society. We are committed to operating in a way that recognizes the interconnection between business growth, the needs of society and the limitations of our planet.
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in healthcare in approximately 80 countries.
Biologix helps multinational pharmaceutical manufacturers bring innovative drugs to market in the Middle East / North Africa (MENA) region. Positioned across 17+ key strategic locations in the Gulf Cooperation Council (GCC), Egypt, North Africa and the Levant, we are pioneers in regional distribution and promotion of innovative products and solutions for difficult-to-treat diseases. A privately owned pharmaceutical company organized under the laws of the United Arab Emirates (UAE), Biologix provides end-to-end solutions from the preregistration phase all the way to commercial-scale market access and risk management. Incorporated in the Dubai Airport Free Zone in September 2002, Biologix traces its history back to 1997. We were among the first organizations to recognize the need for long-term strategic partnerships in the MENA region, and today we connect pharma leaders around the world with integrated direct-access healthcare approaches.
NewBridge Pharmaceuticals, headquartered in Dubai, UAE, is a regional specialty company with a comprehensive pharmaceutical platform of services and expertise, established to bridge the access gap and partner with global pharma and biotech companies to in-license and commercialize U.S. FDA or EMA approved innovative therapeutics that address unmet medical needs into the Middle East and North Africa (MENA) regions.
We put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. Our partners collaborate with us because of our reputation for quality, our strong brand recognition, and our US FDA-inspected manufacturing plants. Organisations we work with know they can rely on us to deliver consistently, in all our markets. We have always been committed to high standards of ethical conduct. In our business and in our dealings with other people. At the heart of this are our three values: Innovation. Caring. Collaboration. These shape the way our people think, work and behave. And ensure the sustainability of our company. In 2017, we achieved the highest ranking of any pharmaceutical company in the UK’s Institute of Directors' Good Governance Report.
Purina Pro Plan is the most advanced nutrition for your pet’s best life. That’s why ae are proud to offer a full spectrum of performance and specialized nutrition formulas, including options that supports healthy ageing, provide guaranteed live probiotics and more. Our innovative nutrition is powered by a team of 500+ nutritionists, veterinarians and scientists. At Purina Pro Plan, we will never stop researching and enhancing the food your pets depends on every day. Make sure to pass by our booth to get the opportunity to know more about a novel nutritional approach that can help neutralize the major cat allergen (Fel d 1) in cats’ saliva, before it spreads to the environment.
We are an international group based in Parma, research-oriented, with over 85 years of experience, present in 30 countries. The Chiesi Group researches, develops and markets innovative drugs in three specific areas: AIR (products and services in the respiratory field, from infants to adults), RARE (innovative solutions and personalized services to improve the quality of life of patients with rare and ultra-rare diseases) and CARE (products and services to support specialist care, personal care and well-being). Since 2019 we are a certified B Corp, while, in 2018, we changed our legal status to a Benefit Company, realizing the desire to measure our impact on society and the environment, combining the need to generate value for the business to acting as a positive force for the community in which we live.
Driven by Our Promise. It began with a promise. CSL Behring's parent company, CSL, was formed more than 100 years ago to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives. We offer the broadest range of quality plasma-derived and recombinant therapies in our industry. Our ability to innovate and deliver life-saving medicines for patients with rare disease and other unmet medical needs around the world has earned us a reputation for always putting patients first. We are CSL Behring and we are driven by our promise.
HVD Life Sciences is a marketing and distribution company that specializes in sourcing, supplying and supporting life science solutions. We bring a global perspective to our business worldwide, covering regions including Central and Southeast Europe, the Middle East, Africa, the Commonwealth of Independent States, the Far East and Latin America. We offer a wide range of high quality products from carefully selected manufacturers of innovative and industry-leading tools and technologies. With all of our suppliers, we focus on building strong relationships that will ensure long-term success for our customers, our partners and ourselves. HVD Life Sciences is not just a reseller. Our relationships with our customers don’t end when we close a sale. At HVD Life Sciences, we all take pride in the expertise we bring to our work. Our customers benefit from local sales and support teams with expert product and application knowledge. We specialize in delivering a streamlined sales process, expert customer support and top quality service. Our comprehensive support and service program is as important to our business as the products we ship.
New Country Healthcare (NCH) was founded in 1978 as Country Pharmacy and evolved to New Country Healthcare in 1990, NCH today is a leader in the healthcare sector, with a rich portfolio that includes over 1500 products manufactured in United States, Canada, Europe, Asia and Middle East. NCH started with a vision of a healthier community by our Chairman Dr. Ghazi Al Koudsi, a UAE board certified pharmacist and consultant to governing agencies. With hard work and dedication, NCH has not only kept their promise to the community but, has also stayed true to the vision of our chairman who inspires every member of the NCH family to give their best every day.
BABIRUS Group is committed to working with healthcare partners across the MENA region to deliver innovative and technologically advanced diagnostic solutions that help to improve people’s health. Headquartered in Dubai, UAE, the company is focused on handling a portfolio of leading global healthcare brands and best in class diagnostic products in three key areas: Molecular Diagnostics, Personalised Medicine, and Immuno Diagnostics. We believe that the key for helping medical specialists to improve patient outcomes is through a continuous program of medical education and trainings as well as offering ongoing scientific support from our highly qualified team.